| Symbol |
Name |
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ATXN1
|
ataxin 1
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
AURKA
|
aurora kinase A
|
|
BBS1
|
Bardet-Biedl syndrome 1
|
|
BBS4
|
Bardet-Biedl syndrome 4
|
|
BHLHA9
|
basic helix-loop-helix family, member a9
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CENPA
|
centromere protein A
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHST3
|
carbohydrate (chondroitin 6) sulfotransferase 3
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
CNOT3
|
CCR4-NOT transcription complex, subunit 3
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CTCFL
|
CCCTC-binding factor (zinc finger protein)-like
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11
|
|
DES
|
desmin
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOK7
|
docking protein 7
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSC2
|
desmocollin 2
|
|
EFHC2
|
EF-hand domain (C-terminal) containing 2
|
|
ELOVL4
|
ELOVL fatty acid elongase 4
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FECH
|
ferrochelatase
|
|
FGA
|
fibrinogen alpha chain
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FHL1
|
four and a half LIM domains 1
|
|
FLG
|
filaggrin
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXE3
|
forkhead box E3
|
|
FOXL2
|
forkhead box L2
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDAP1
|
ganglioside induced differentiation associated protein 1
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GHRH
|
growth hormone releasing hormone
|
|
GJA8
|
gap junction protein, alpha 8, 50kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB3
|
gap junction protein, beta 3, 31kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HADH
|
hydroxyacyl-CoA dehydrogenase
|
|
HAND2
|
heart and neural crest derivatives expressed 2
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
|
HFE
|
hemochromatosis
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HP
|
haptoglobin
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPSE2
|
heparanase 2 (inactive)
|
|
IL10
|
interleukin 10
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
INHA
|
inhibin, alpha
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
KANK1
|
KN motif and ankyrin repeat domains 1
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KIF21A
|
kinesin family member 21A
|
|
KIR2DS3
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KRT17
|
keratin 17, type I
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRSAM1
|
leucine rich repeat and sterile alpha motif containing 1
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
LY6E
|
lymphocyte antigen 6 complex, locus E
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MARK2
|
MAP/microtubule affinity-regulating kinase 2
|
|
MAT1A
|
methionine adenosyltransferase I, alpha
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MFN2
|
mitofusin 2
|
|
MIRLET7A1
|
microRNA let-7a-1
|
|
MLH1
|
mutL homolog 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MUTYH
|
mutY homolog
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYH7B
|
myosin, heavy chain 7B, cardiac muscle, beta
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
OCA2
|
oculocutaneous albinism II
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PCDH19
|
protocadherin 19
|
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PODXL
|
podocalyxin-like
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
RB1
|
retinoblastoma 1
|
|
RBAK
|
RB-associated KRAB zinc finger
|
|
RET
|
ret proto-oncogene
|
|
RGR
|
retinal G protein coupled receptor
|
|
RHO
|
rhodopsin
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RTEL1
|
regulator of telomere elongation helicase 1
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
SALL1
|
spalt-like transcription factor 1
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELE
|
selectin E
|
|
SELENBP1
|
selenium binding protein 1
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SFTPC
|
surfactant protein C
|
|
SLC29A3
|
solute carrier family 29 (equilibrative nucleoside transporter), member 3
|
|
SLC30A2
|
solute carrier family 30 (zinc transporter), member 2
|
|
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC4A11
|
solute carrier family 4, sodium borate transporter, member 11
|
|
SLC7A9
|
solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9
|
|
SMAD3
|
SMAD family member 3
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPAST
|
spastin
|
|
STOML2
|
stomatin (EPB72)-like 2
|
|
TBX6
|
T-box 6
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TMC6
|
transmembrane channel-like 6
|
|
TMC8
|
transmembrane channel-like 8
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPO
|
thyroid peroxidase
|
|
TPSAB1
|
tryptase alpha/beta 1
|
|
TPSB2
|
tryptase beta 2 (gene/pseudogene)
|
|
TTR
|
transthyretin
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VWF
|
von Willebrand factor
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
ZNRD1
|
zinc ribbon domain containing 1
|
|
ZP1
|
zona pellucida glycoprotein 1 (sperm receptor)
|